With China’s growing power and recent market shifts, it’s time for investors to reconsider commodities over richly valued US ...

US faces economic headwinds in 2025 as tariffs, deficit concerns, and government spending cuts dominate fiscal negotiations.

Stellar performance leads to swathe of glowing research notes. Plus, Pilbara chief cites ‘incredibly strong’ long-term ...

Russia's invasion of Ukraine has untethered gold's correlation to real interest rates and threatens to extend an ongoing bull ...

That's because the Australian Dollar Trade Weighted Index (A$ TWI) is now below 60%. On a 12-month view, Nicol says "that ...

The prospect of the new Trump administration raising tariffs may have helped push up interest rate expectations, bond yields, ...

Below is a summary of the topics we covered on Nucleus Investment Insights this month. See the links for more information.

Although RMD has re-rated from its share price low of around $21.50 in October 2023, it has only just surpassed its all-time ...

A Berkshire Hathaway owned lender is being sued by the US Government for predatory lending. Corporate credit spreads ended ...

Real Asset Management's Matthew Strotton is bullish on this often overlooked area of healthcare real estate investing.

Perpetual is arguably worth $30 a share and potentially more over time. This is why we have seen so many bids for the ...

The Nasdaq recently dropped 3% in a day, following the release of DeepSeek’s AI model. The Chinese start-up’s model boasts to ...